| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/10/2006 | EP1412354B1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1307189B1 Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 05/10/2006 | EP1214091B1 Therapies for chronic renal failure using one or more integrin antagonists |
| 05/10/2006 | EP1194525B1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 05/10/2006 | EP1137948B1 Methods and compositions to lower plasma cholesterol levels |
| 05/10/2006 | EP0946151B1 Ascending-dose dosage form |
| 05/10/2006 | EP0790062B1 Method of testing for myocarditis and cariomyopathy |
| 05/10/2006 | CN1771045A A composition (RCUD) for protecting and/or repairing DNA from oxidative damages and a method thereof |
| 05/10/2006 | CN1771040A Remedy for diabetes. |
| 05/10/2006 | CN1771030A Methods for treatment of parkinson's disease |
| 05/10/2006 | CN1771029A Combination of desoxypeganine and mecamylamine for the treatment of alcohol abuse |
| 05/10/2006 | CN1771028A Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema |
| 05/10/2006 | CN1770976A Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 05/10/2006 | CN1768867A PPMA(polymethyl methacrylate) bone cement containing antibiotic |
| 05/10/2006 | CN1768861A Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/10/2006 | CN1768858A Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 05/10/2006 | CN1768857A Wrinkle- and scar-removing injection |
| 05/10/2006 | CN1768856A Method for preparing injection for removing wrinkles and scars |
| 05/10/2006 | CN1768749A Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 05/10/2006 | CN1768745A Agents for improving excretory potency of urinary bladder |
| 05/10/2006 | CN1768735A Medicaments for diabetic complication and neuropathy, and uses thereof |
| 05/10/2006 | CN1768733A Application of aromatic nitro compound in preparation of medicine for treating AIDS |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255427C Method and composition for treating liver cell cancer |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/09/2006 | US7041835 (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 05/09/2006 | US7041806 Netrin receptors |
| 05/09/2006 | US7041790 Fibrinogen binding moieties |
| 05/09/2006 | US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 05/09/2006 | US7041704 Particularly a tetrodotoxin-resistant voltage-gated Na+ current (TTX-R INa) and/or activity-dependent sodium channel modulators to treat inflammatory bowel disorders, irritable bowel syndrome, slow-transit constipation, non-ulcer dyspepsia, an evacuation an evacuation disorder and functional dysphasia |
| 05/09/2006 | US7041699 Ascorbic compound; L-lysine compound; c) L-proline compound; and d) epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin, or catechin; blocking cancer proliferation and metastasis. |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041676 Compounds, compositions, and methods |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041666 Adenosine A2a receptor antagonists |
| 05/09/2006 | US7041658 topically administering a neutral endopeptidase inhibitor that is an N-aminocarbonylmethyl-substituted phosphonamide or phosphoramide |
| 05/09/2006 | US7041640 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/09/2006 | US7041634 Method of inhibiting immune system destruction of transplanted viable cells |
| 05/09/2006 | US7041504 Cancer cell-inhibiting culture medium produced by culturing restricted entrapped cancer cells |
| 05/09/2006 | US7041494 DNA encoding Slo2 and Slo4, potassium channel |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041449 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041321 supercritically extracting an herb to obtain an oil extract and a residue;extracting the residue in a water/alcohol liquid mixture to obtain a post-supercritical hydroalcoholic extract; evaporating the water/alcohol liquid to form a powdered extract; mixing the powdered extract with the oil extract. |
| 05/09/2006 | US7041316 Stable oral pharmaceutical dosage forms |
| 05/09/2006 | US7041314 GPE analogs and peptidominetics |
| 05/09/2006 | US7041302 Therapeutic modulation of the tumor inflammatory response |
| 05/09/2006 | US7041301 Interferon immunotherapy |
| 05/09/2006 | US7041294 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041276 Administering the agent to a teleost and detecting a response in the teleost indicating angiogenesis activity |
| 05/09/2006 | US7041241 Microspheres contain 5-fluorouracil coated with poly(d-l-lactic acid-co-glycolic acid); implanted in walls of operation site following exeresis of tumor, by intratissular injection |
| 05/09/2006 | US7041063 Noninvasive measurement of chemical substances |
| 05/09/2006 | US7040311 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage |
| 05/09/2006 | CA2175687C A bacterial nitroreductase gene-prodrug system |
| 05/04/2006 | WO2006047574A1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/04/2006 | WO2006047522A1 Hypoestoxides, derivatives, agonists and crude extracts thereof for use in topical compositions |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006046958A1 Decongestant and expectorant system |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006046735A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/04/2006 | WO2006046689A1 Remedy for endometriosis |
| 05/04/2006 | WO2006046623A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 05/04/2006 | WO2006045963A2 Composition of cosmetic or pharmacological application for stimulation of synthesis of collagen |
| 05/04/2006 | WO2006045756A1 Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases |
| 05/04/2006 | WO2006045640A1 Method of using adapalene in acne maintenance therapy |
| 05/04/2006 | WO2006045238A1 Carbonized pollen and the use thereof for the preparation of anticancer drugs |
| 05/04/2006 | WO2006006172A3 Use of anti-amyloid agents for treating and typing pathogen infections |
| 05/04/2006 | WO2005115461A3 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 05/04/2006 | WO2005089750A3 Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor |
| 05/04/2006 | WO2005089749A3 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder |
| 05/04/2006 | WO2004004708A9 A pharmaceutical composition useful for treating chronic myeloid leukemia |
| 05/04/2006 | US20060094783 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094766 Epothilone derivatives for the treatment of multiple myeloma |
| 05/04/2006 | US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094723 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 05/04/2006 | US20060094722 Combination drug |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline |
| 05/04/2006 | US20060094698 Self-administered contraceptive injection of oily solution |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094674 Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms |
| 05/04/2006 | US20060094671 With (-)-2'-deoxy-3'-thiocytidine-5'-triphosphate; immunomodulators; nucleosides |
| 05/04/2006 | US20060094660 Inhibitor of the shh signalling patway and a testosterone supressing agent for the treatment of cancer |
| 05/04/2006 | US20060094657 Inhibiting development of microvessels within coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy |
| 05/04/2006 | US20060094654 Neuroprotective complex for treatment of cerebral ischemia and injury |
| 05/04/2006 | US20060094608 Mixture of polyol and insulation agent; heating upon exposure to moisture; for urogenital systems; dysmenorrhea |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060094007 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 05/04/2006 | US20060093687 Administering N-(2-bromophenyl)-N'-[((R)-1-(5-trifluoromethyl-2-pyridyl)pyrrolidin-3-yl)]urea and rofecoxib |
| 05/04/2006 | US20060093662 Liposomal camptothecins and uses thereof |
| 05/04/2006 | US20060093627 Method of protecting chronic infections |